The journal of medicine access最新文献

筛选

英文中文

Telemedicine in a primary care clinic in Fairbanks, Alaska: Not a magic bullet for providing treatment during COVID-19. 阿拉斯加费尔班克斯初级保健诊所的远程医疗:不是在COVID-19期间提供治疗的灵丹妙药。

The journal of medicine access Pub Date : 2022-04-03 eCollection Date: 2022-01-01 DOI: 10.1177/27550834221085878

Sarah Yt Hartzell

{"title":"Telemedicine in a primary care clinic in Fairbanks, Alaska: Not a magic bullet for providing treatment during COVID-19.","authors":"Sarah Yt Hartzell","doi":"10.1177/27550834221085878","DOIUrl":"https://doi.org/10.1177/27550834221085878","url":null,"abstract":"Stay-at-home orders due to the COVID-19 pandemic have increased patients' reliance on virtual physician visits, via telemedicine. Telemedicine has benefits of use during the pandemic and has benefits outside of the pandemic. It is underutilized in certain types of medical organizations, providers, and among specific populations in the United States. It is important to understand the barriers to incorporating telemedicine effectively in the areas that it is underutilized, especially in rural locations. The researcher discussed the telemedicine expansion for two family practice doctors in Fairbanks, Alaska (AK). The family practice doctors experienced barriers that partially echo what has been stated in research. Research suggests that changes to Medicare and Medicaid telemedicine policies may not be enough to address these barriers. Other supports to expand telemedicine where it is needed includes providing more incentives to providers, waivers from insurance companies for patients to purchase equipment, and more education to patients about when, how, and where to receive telemedicine. More supports need to be provided to those underserved by telemedicine, especially for clients who are on Medicaid, living in low-income areas, and/or living in rural locations.","PeriodicalId":75087,"journal":{"name":"The journal of medicine access","volume":" ","pages":"27550834221085878"},"PeriodicalIF":0.0,"publicationDate":"2022-04-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/a8/80/10.1177_27550834221085878.PMC9413496.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"33492079","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 1

A critical review on the availability of substandard and falsified medicines online: Incidence, challenges and perspectives. 对网上伪劣药品可得性的批判性审查:发生率、挑战和前景。

The journal of medicine access Pub Date : 2022-02-15 eCollection Date: 2022-01-01 DOI: 10.1177/23992026221074548

Jamee Ahmed, Laura Modica de Mohac, Tim K Mackey, Bahijja Tolulope Raimi-Abraham

{"title":"A critical review on the availability of substandard and falsified medicines online: Incidence, challenges and perspectives.","authors":"Jamee Ahmed, Laura Modica de Mohac, Tim K Mackey, Bahijja Tolulope Raimi-Abraham","doi":"10.1177/23992026221074548","DOIUrl":"https://doi.org/10.1177/23992026221074548","url":null,"abstract":"Simultaneous expansion of the Internet and increased globalisation of the pharmaceutical industry have meant medication can be accessed transnationally from both legal and illicit sources. This has coincided with the rise of substandard and falsified medicines (SFMs) online. These products fail to meet regulatory or quality standards and/or are constituted with substandard ingredients, causing undesired pharmacological effects, including possible injury and death. This review aimed to identify original research studies that examined characteristics of SFM online sales, attitudes towards purchasing medicines online and strategies to address this drug safety challenge. Keywords of 'Substandard' and 'Falsified'/'Counterfeit' and 'Medicines'/'Drugs' and 'Online'/'Internet' were searched using Web of Knowledge and PubMed databases. Resulting literature, which satisfied the study's inclusion criteria, was included in the review, and the findings from each paper were assessed. From an initial 185 literature articles, 7 were eligible according to the inclusion criteria to be reviewed. These articles identified studies testing SFMs purchased online, surveys of attitudes and knowledge about SFMs online, and website content analysis to detect illegal online sales. Challenges identified were lack of knowledge and awareness among consumers and physicians, in addition to the use of direct-to-consumer-advertising, via Internet platforms and social media, providing easy access to SFMs. Despite this, medicine authentication technology, website verification approaches and new detection methods were identified as potential solutions specific to online SFM sales. To address online sales of SFMs, more robust research, greater awareness/educational programmes, analytical detection methods and more stringent online global governance are required.","PeriodicalId":75087,"journal":{"name":"The journal of medicine access","volume":" ","pages":"23992026221074548"},"PeriodicalIF":0.0,"publicationDate":"2022-02-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9413502/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"33510520","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 7

Tackling the global impact of substandard and falsified and unregistered/unlicensed anti-tuberculosis medicines. 应对不合格、伪造和未注册/未经许可的抗结核药物的全球影响。

The journal of medicine access Pub Date : 2022-01-23 eCollection Date: 2022-01-01 DOI: 10.1177/23992026211070406

Tamara Akpobolokemi, Rocio Teresa Martinez-Nunez, Bahijja Tolulope Raimi-Abraham

{"title":"Tackling the global impact of substandard and falsified and unregistered/unlicensed anti-tuberculosis medicines.","authors":"Tamara Akpobolokemi, Rocio Teresa Martinez-Nunez, Bahijja Tolulope Raimi-Abraham","doi":"10.1177/23992026211070406","DOIUrl":"https://doi.org/10.1177/23992026211070406","url":null,"abstract":"Substandard and falsified (SF) medicines are a global health challenge with the World Health Organization (WHO) estimating that 1 in 10 of medicines in low- and middle-income countries (LMICs) are SF. Antimicrobials (i.e. antimalarials, antibiotics) are the most commonly reported SF medicines. SF medicines contribute significantly to the global burden of infectious diseases and antimicrobial resistance (AMR). This article discusses the challenges associated with the global impact of SF and unregistered/unlicensed antimicrobials with a focus on anti-TB medicines. Tuberculosis (TB) is the 13th leading cause of death worldwide, and is currently the second leading cause of death from a single infectious agent, ranking after COVID-19 and above HIV/AIDS. Specifically in the case of TB, poor quality of anti-TB medicines is among the drivers of the emergence of drug-resistant TB pathogens. In this article, we highlight and discuss challenges including the emergence of SF associated AMR, patient mistrust and lack of relevant data. We also present study reports to inform meaningful change. Recommended solutions involve the adaptation of interventions from high-income countries (HICs) to LMICS, the need for improvement in the uptake of medication authentication tools in LMICs, increased stewardship, and the need for global and regional multidisciplinary legal and policy cooperation, resulting in improved legal sanctions.","PeriodicalId":75087,"journal":{"name":"The journal of medicine access","volume":" ","pages":"23992026211070406"},"PeriodicalIF":0.0,"publicationDate":"2022-01-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9413333/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"33492078","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 3

首页上一页